Methods and compositions for rna interference
AssigneeCold Spring Harbor Laboratory
InventorsGregory J. HANNON, Patrick Paddison, Emily Bernstein, Amy Caudy, Douglas Conklin, Scott Hammond
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for attenuating gene expression in a cell, especially in a mammalian cell, using gene-targeted double stranded RNA (dsRNA), such as a hairpin RNA. The dsRNA contains a nucleotide sequence that hybridizes under physiologic conditions of the cell to the nucleotide sequence of at least a portion of the gene to be inhibited (the “target” gene).
Claims11
1-35. (canceled)
A transgenic mouse comprising a germline or somatic cell, wherein the germline or somatic cell comprises a transgene, wherein the transgene comprises a sequence encoding a short hairpin RNA (shRNA) molecule,
- wherein the shRNA molecule comprises a double-stranded region, wherein the double-stranded region consists of at least 20 nucleotides but not more than 29 nucleotides,
- wherein the shRNA molecule is a substrate for Dicer-dependent cleavage and does not trigger a protein kinase RNA-activated (PK) response in the mammalian cell,
- wherein the double-stranded region of the shRNA molecule comprises a sequence that is complementary to a portion of a target gene, and
- wherein the shRNA molecule is stably expressed in said germline or somatic cell without use of a PK inhibitor and in an amount sufficient to attenuate expression of the target gene in a sequence specific manner.
A method for attenuating expression of a target gene in germline or somatic cells of a transgenic mouse, the method comprising:
- (a) introducing into a mouse embryonic stem cell a sequence encoding a short hairpin RNA (shRNA) molecule comprising a double-stranded region, wherein the double-stranded region consists of at least 20 nucleotides but not more than 29 nucleotides,
- wherein the shRNA molecule is a substrate for Dicer-dependent cleavage,
- wherein the double-stranded region of the shRNA molecule comprises a sequence that is complementary to a portion of said target gene,
- (b) generating a transgenic mouse from the mouse embryonic stem cell of step (a), said transgenic mouse comprising germline or somatic cells,
- wherein the germline or somatic cells comprise a transgene,
- wherein the transgene comprises a sequence encoding a short hairpin RNA (shRNA) molecule,
- wherein the shRNA molecule is stably expressed in said germline or somatic cells without use of a PK inhibitor and in an amount sufficient to attenuate expression of the target gene in a sequence specific manner,
- wherein the shRNA molecule does not trigger a protein kinase RNA-activated (PK) response in the germline or somatic cell,
- whereby expression of the target gene is inhibited in said germline or somatic cells.
Dependencies are inferred from the claim text.